Hilary Marston, M.D., M.P.H., served for more than a decade as a leader and strategic advisor on national public health policy and is a recognized expert in the clinical and regulatory aspects of medical product and vaccine development. She brings this expertise to her work with biotechnology and drug companies and investors at Canal Row, and prior to this, at Marston Health, LLC, which she founded after her tenure in FDA leadership.
Dr. Marston was FDA’s inaugural Chief Medical Officer, serving as the primary clinical advisor to the Commissioner and leading the office that oversees clinical matters involving multiple FDA product development centers, including financial incentives (e.g., for rare disease product development), targeted grantmaking, and research participant protection policy. She also led the Agency’s response to health crises, including epidemics and medical product shortages.
Dr. Marston previously served as Senior Advisor for Global COVID-19 Response on the White House COVID-19 Response Team, as Director for Medical Biopreparedness and Response at the U.S. National Security Council, and as Policy Advisor for Pandemic Preparedness at the National Institute of Allergy and Infectious Diseases. She also worked at McKinsey & Company and the Bill & Melinda Gates Foundation.
Dr. Marston trained in Internal Medicine and Global Health Equity at Brigham & Women’s Hospital. She completed her M.P.H. at the Harvard School of Public Health.